Changes in breast cancer incidence and stage distribution in Modena, Italy: The effect of a mammographic screening program

Cancer Causes and Control

Volumn 13, Issue 8, 2002, Pages 729-734

  Turchetti, Daniela ^a   Mangone, Lucia ^a   Negri, Rossella ^b   Rossi, Giulio ^c   Cortesi, Laura ^a   Vinceti, Marco ^d   Maiorana, Antonino ^c   Gallo, Ennio ^e   Federico, Massimo ^a,e  

^a Cattedra e Divisione di Oncologia Medica   (Italy)

^b AUSL Modena   (Italy)

^c Istituto di Anatomia Patologica   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Breast cancer incidence; Breast cancer stage; Mammographic screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; FEMALE; HEALTH PROGRAM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; ITALY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 0036799889     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020208719902     Document Type: Article

References (24)

1. Mettlin C (1999) Global breast cancer mortality statistics. CA Cancer J Clin 49: 138-144.
2. Federico M, Mangone L, Maiorana A. De Girolamo G (2001) I Tumori in Provincia di Modena Nel Biennio 1996-97. Modena: Progress.
3. Peto R, Boreham J, Clarke M, Davies C, Beral V (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355: 1822.
4. Howe HL, Wingo PA, Thun MJ, et al. (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancer with recent increasing trends. J Natl Cancer Inst 93: 824-842.
5. Coleman MP (2000) Trends in breast cancer incidence, survival and mortality. Lancet 356: 590-591.
6. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: An overview of randomised trials. Lancet 351: 1451-1467.
7. Early Breast Cancer Trialists' Collaborative Group (1998) Polichemotherapy for early breast cancer: An overview of the randomised trials. Lancet 352: 930-942.
8. Tabàr L, Fagerberg G, Gad A, et al. (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish national Board of Health and Welfare. Lancet 1: 829-832.
9. Kierlikowske K, Grady D, Rubin SM, Sandrock C, Ernster V (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273: 149-154.
10. Day ME, Williams DRR, Khaw KT (1989) Breast cancer screening programmes. The development of a monitoring and evaluation system. Br J Cancer 59: 954-958.
11. Ries LAG, Eisner MP, Kosary CL, et al. (2001) SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute.
12. Barchielli A, Paci E (2001) Trends in breast cancer mortality, incidence and survival, and mammographic screening in Tuscany, Italy. Cancer Causes Control 12: 249-255.
13. Paci E, Ciatto S, Buiatti E, Cecchini S, Palli D, Rosselli del Turco M (1990) Early indicators of efficacy of breast cancer screening programmes. Results of the Florence screening programme. Int J Cancer 46: 198-202.
14. Parkin DM, Whelan SL, Ferlay J, et al. (1997) Cancer Incidence in Five Continents, Vol. VII. Lyon: International Agency for Research on Cancer; IARC Scientific Publication No. 143, pp. 542-545.
15. Sobin LH, Wittekind CH, eds. International Union Against Cancer. (1997) TNM Classification of Malignant Tumours, 5th edn. New York: Wiley.
16. Fagerberg G, Baldetorp L, Gröntoft O, Lundström B, Månson JC, Nordenskjöld B (1985) Effects of repeated mammographic screening on breast cancer stage distribution. Acta Radiol 24: 465-473.
17. White E, Yul Lee C, Kristal AR (1990) Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 82: 1546-1552.
18. Lantz PM, Remington PL, Newcomb PA (1991) Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst 83: 1540-1546.
19. Quinn M, Allen E (1995) Changes in incidence and mortality from breast cancer in England and Wales since the introduction of screening. BMJ 311: 1391-1395.
20. Brewster D, Everington D, Harkness E, Gould A, Warner J (1996) Incidence and mortality from breast cancer since the introduction of screening. BMJ 312: 638-639.
21. McCann J, Wait S, Séradour B, Day N (1997) A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches Du Rhône, France. Eur J Cancer 33: 429-435.
22. McCann J, Stockton D, Day N (1998) Breast cancer in East Anglia: The impact of the breast screening program on stage at diagnosis. J Med Screen 5: 42-48.
23. Harmer C, Staples M, Kavanagh AM (1999) Evaluation of breast cancer incidence: Is the increase due entirely to mammographic screening? Cancer Causes Control 10: 333-337.
24. Fracheboud J, De Koning HJ, Beemsterboer PM, et al. (1998) Nation-wide breast cancer screening in the Netherlands: results of initial and subsequent screening 1990-1995. National evaluation team for breast cancer screening. Int J Cancer 75: 694-698.